Neurocrine Biosciences Total Change in Assets/Liabilities 2010-2025 | NBIX
Neurocrine Biosciences total change in assets/liabilities for the twelve months ending March 31, 2025 was $-0.274B, a 339.77% decline year-over-year.
- Neurocrine Biosciences annual total change in assets/liabilities for 2024 was $-0.019B, a 168.09% decline from 2023.
- Neurocrine Biosciences annual total change in assets/liabilities for 2023 was $0.028B, a 141.84% decline from 2022.
- Neurocrine Biosciences annual total change in assets/liabilities for 2022 was $-0.067B, a 503.59% decline from 2021.